Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| NCI-2019-02478 | Other Identifier | Clinical Trials Reporting Program (CTRP) |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This research study is to learn about breast cancer patients' opinions about screening for lymphedema (a side effect of breast cancer treatment in which the arm can become heavy, painful, and/or swollen) and their satisfaction with the lymphedema screening program.
Primary Objectives:
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Cohort I (patients receiving annual lymphedema screening) | Other | We will retrospectively retrieve information on patients who previously underwent preoperative perometer lymphedema screening during the past year who were treated definitively for their breast cancer with an ALND, and for whom no follow-up postoperative lymphedema screening was done. |
|
| Cohort II (patients followed intensively for lymphedema) | Other | We will prospectively follow a cohort of 279 patients who have recently undergone ALND in this upcoming year with intensive lymphedema screening. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Cohort I (patients receiving annual lymphedema screening | Other | patientns who previously underwent preoperative perometer lymphedema screening |
|
| Measure | Description | Time Frame |
|---|---|---|
| To establish the effectiveness of prospective, intensive lymphedema screening in the postoperative setting using a perometer. | through study completion, an average of 1 year |
Not provided
Not provided
Inclusion Criteria:
a Cohort A:
b Cohort I:
c Cohort II:
Exclusion Criteria:
Inability to complete a self-administered questionnaire
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Simona Shaitelman | M.D. Anderson Cancer Center | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| M D Anderson Cancer Center | Houston | Texas | 77030 | United States |
Not provided
| Label | URL |
|---|---|
| M D Anderson Cancer Center | View source |
Not provided
Not provided
| ID | Term |
|---|---|
| D008209 | Lymphedema |
| ID | Term |
|---|---|
| D008206 | Lymphatic Diseases |
| D006425 | Hemic and Lymphatic Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Cohort II (patients followed intensively for lymphedema) | Other | patients who have recently undergone ALND |
|